Xamoterol fumarate

This classification denotes a beta-adrenergic agonist 2C16H25N3O5.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N87007N668, chemically known as ici-118,587 hemifumarate, but more generally known as xamoterol fumarate, which bears US NIH Compound Identifier 6917710. European Medicines Agency schedules Xamoterol fumarate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05144MIG. Most nations, for tariff and trade purposes, schedule xamoterol fumarate under HS 29349990 and SITC 51579. As of Q4 2014, XAMOTEROL FUMARATE remains US FDA's Preferred Term for this commodity. SMILES: C1CC(CCC1O)OCC(CNCCNC(=O)N2CCOCC2)O.C1CC(CCC1O)OCC(CNCCNC(=O)N2CCOCC2)O.C(=C/C(=O)O)\C(=O)O.